12325 Emmett Street
278 articles about Transgenomic, Inc.
Ilan Danieli, chief executive officer and co-founder of Precipio, a company with a liquid biopsy technology, took time to talk to BioSpace about the company and the economics of liquid biopsies.
Precipio Diagnostics And Transgenomic, Inc. Complete Merger
Transgenomic, Inc. Prepares For Planned Relisting On NASDAQ
Precipio Diagnostics And Transgenomic, Inc. Announce Experts From Yale And Harvard Joining New Scientific Advisory Board To Support Merged Company’s Growth Initiatives
European Patent Office Confirms Grant Of New ICE COLD-PCR Patent Exclusively Licensed To Transgenomic, Inc.
Transgenomic, Inc. Stockholders And Precipio Diagnostics Members Approve Merger
Transgenomic, Inc. Board Confirms Date And Location Of Special Meeting Of Stockholders And Announces Reverse Stock Split Ratio
Transgenomic, Inc. Closes Bridge Financing
Transgenomic, Inc. Provides Update On Its Planned Merger And Reports Change In Listing Status
Transgenomic, Inc. Release: Company Announces Leading Clinical Laboratory Services Provider LifeLabs Selects ICE COLD-PCR As Its Mutation Enrichment Platform
Transgenomic, Inc. And Precipio Diagnostics Announce Planned Merger
Transgenomic, Inc. Adds New Distributors In China And India For Its ICEme Kits That Enable Liquid Biopsy Cancer Testing On Existing Platforms
Transgenomic, Inc. And Ventana Medical Systems Complete Data Sharing Agreement
Transgenomic, Inc. Reports Second Quarter 2016 Financial Results
Transgenomic, Inc. To Hold Second Quarter 2016 Results Conference Call On August 12, 2016 At 5:00 PM EDT
VWR To Distribute Transgenomic, Inc.’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research On Existing Platforms
Transgenomic, Inc. Launches First Commercially Available CLIA Test For Detection Of EGFR C797S Mutations That Predict Resistance To 3rd Generation Kinase Therapies For Lung Cancer
Transgenomic, Inc. Licenses Commercial Rights To Its Long QT Syndrome DNA Testing Portfolio To LabCorp
Transgenomic, Inc. Accelerates Commercialization Of ICE COLD-PCR (ICP) Amid Plans To Expand Cancer Product Line Ten-Fold
ASCO2016: Transgenomic, Inc. Releases New Data At ASCO 2016 Confirming Concordance Of ICE COLD-PCR (ICP) Liquid And Tissue Biopsies